Avidity Biosciences, Inc.【RNA】Balance sheet

Market cap

$9.3B

P/E ratio

	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	321	320	341	185	223
Marketable securities, current	7	85	-	-	-
Total cash & short-term investments	328	406	341	185	223
Total current assets	332	411	623	611	1,542
Property, plant and equipment, net	1	5	6	8	13
Total non-current assets	2	16	16	17	22
Total assets	334	428	639	629	1,564
Total current liabilities	15	30	52	81	98
Total non-current liabilities	13	16	9	47	41
Total liabilities	28	46	61	128	139
Common stock and paid-in capital	373	566	939	0	0
Retained earnings	-67	-184	-358	-571	-893
Stockholders' equity	306	381	578	501	1,425